Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 184

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 9B
Chunk 184
---

    56,250

    7.71

    10,336,883

    6.91

    9,424,826

    6.76

Warrants

The
following is a summary of the Company’s warrant activity for the year ended December 31, 2024 and 2023:

Schedule of Warrant Activity

    Number of Shares  
    Weighted Average Exercise Price per
    Share  
    Weighted Average Remaining Life (Years) 
  
    Outstanding as of December 31, 2022 
     1,359,375  
    $0.80  
     0.98 
  
    Granted 
     -  
     -  
     - 
  
    Forfeited 
     -  
     -  
     - 
  
    Outstanding as of December 31, 2023 
     1,359,375  
    $0.80  
     0.64 
  
    Granted 
     -  
     -  
     - 
  
    Forfeited 
     -  
     -  
     - 
  
    Outstanding as of December 31, 2024 
     1,359,375  
    $0.80  
     0.93 

    F-20

JUPITER
NEUROSCIENCES, INC.

NOTES
TO FINANCIAL STATEMENTS

December
31, 2024 and 2023

Note
6 – Stockholders’ Equity (Deficit), continued

Restricted
Stock Units

On
September 29, 2023, the Company issued an aggregate of 1,399,834 restricted stock units with a grant date value of $1.33 per unit in
exchange for the forgiveness of accrued compensation. Pursuant to the amendment dated December 18, 2023, the restricted stock units shall
vest on the on earlier event of either the occurrence of an initial public offering or in the event of change of control of the Company.
The restricted stock units have an aggregate grant date fair value of $1,866,445.

On
December 18, 2023, the Company terminated 1,399,384 restricted stock units and issued an aggregate of 1,618,537 restricted stock units
with a grant date value of $1.33 in exchange for the forgiveness of